Search

Embecta Corp

Slēgts

SektorsVeselības aprūpe

4.42 26.65

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

3.51

Max

4.68

Galvenie mērījumi

By Trading Economics

Ienākumi

-48M

-4.1M

Pārdošana

-39M

222M

P/E

Sektora vidējais

1.928

68.51

EPS

0.27

Dividenžu ienesīgums

16.48

Peļņas marža

-1.849

Darbinieki

1,850

EBITDA

-51M

45M

Rekomendācijas

By TipRanks

Rekomendācijas

Pārdot

Prognoze 12 mēnešiem

-14.29% downside

Dividendes

By Acuity

Dividenžu ienesīgums

Sektora vidējais

16.48%

2.29%

Nākamie ieņēmumi

2026. g. 7. aug.

Nākamais dividenžu datums

2026. g. 15. sept.

Nākamais Ex dividenžu datums

2026. g. 27. aug.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-327M

221M

Iepriekšējā atvēršanas cena

-22.23

Iepriekšējā slēgšanas cena

4.42

Ziņu noskaņojums

By Acuity

72%

28%

308 / 340 Rangs Healthcare

Embecta Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 6. aug. 23:42 UTC

Embecta Corp shares are higher in after-market hours, recovering from earlier lows. No specific news was identified to explain this movement.

2026. g. 5. aug. 22:36 UTC

News

Embecta Corp faces a securities fraud class action lawsuit over misleading fiscal statements, contributing to a modest decline in after-market trading.

2026. g. 4. aug. 19:26 UTC

Embecta Corp shares are higher during Tuesday's session, reaching a session high. No specific company news was identified to explain the upward movement.

2026. g. 3. aug. 20:03 UTC

Embecta Corp shares are higher today, benefiting from positive investor sentiment in the health care supplies sector amid a rising broader market.

2026. g. 31. jūl. 21:02 UTC

Embecta Corp shares are lower in after-market hours, continuing a recent decline amid broader market concerns over inflation and rising interest rates.

2026. g. 30. jūl. 21:02 UTC

Embecta Corp shares are higher in after-market trading, amid positive market sentiment focused on corporate earnings despite geopolitical tensions and inflation concerns.

2026. g. 29. jūl. 19:04 UTC

Embecta Corp gains amid a strong Health Care Supplies sub-sector, despite pulling back from earlier session highs. Overall, shares are higher since Tuesday's close.

2026. g. 28. jūl. 22:01 UTC

Embecta Corp shares are higher in after-market hours, continuing a positive trend since Tuesday's close. No specific news was identified to explain the movement.

2026. g. 27. jūl. 18:03 UTC

Embecta Corp shares are trading higher, continuing a rise since Friday amid broader market movements and easing inflation concerns, despite earlier pulling back from session highs.

2026. g. 24. jūl. 21:31 UTC

News

Embecta Corp is facing a securities class action lawsuit for allegedly misleading investors about its fiscal results, contributing to lower after-market hours trading.

2026. g. 22. jūl. 18:02 UTC

News

Embecta Corp shares are lower today amid a securities fraud class action lawsuit filed by Levi & Korsinsky, LLP, targeting misrepresentation of financial health.

2026. g. 21. jūl. 23:01 UTC

Embecta Corp shares are higher in after-market trading, reflecting a strong position above its 20-day moving average and near the upper end of its one-month range.

2026. g. 20. jūl. 19:52 UTC

Embecta Corp shares are rising sharply, reaching the upper end of their one-month range amid positive broader market sentiment, particularly from Asian markets.

Salīdzinājums

Cenas izmaiņa

Embecta Corp Prognoze

Cenas mērķis

By TipRanks

-14.29% uz leju

Prognoze 12 mēnešiem

Vidējais 3 USD  -14.29%

Augstākais 3 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Embecta Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pārdot

2 ratings

0

Pirkt

1

Turēt

1

Pārdot

Noskaņojums

By Acuity

308 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat